Details for This Review

Study Population: 8,805 patients with proven or suspected acute bacterial conjunctivitis

Efficacy End Points: Clinical effectiveness (i.e., clinical cure); resolution of at least two of the following three signs after a course of antibiotic therapy: bulbar conjunctival injection, palpebral conjunctival injection, and any purulent epiphora

Harm End Points: Antibiotic-associated ocular or systemic complications

Narrative: In the United States, acute conjunctivitis is estimated to occur in 6 million people annually, making up 1% of all primary care visits.^1,2 Acute conjunctivitis can be caused by allergy or infection (bacterial, viral, and less commonly fungal).